(βR,δS)-2-(4-Fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid

(βR,δS)-2-(4-Fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Struktur
651770-09-1
CAS-Nr.
651770-09-1
Englisch Name:
(βR,δS)-2-(4-Fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid
Synonyma:
Atorvastatin calcium impurity B02;(3R,5S)-Atorvastatin EP Impurity B (single configuration) Calcium salt;(βR,δS)-2-(4-Fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid;1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, (βR,δS)-
CBNumber:
CB85989610
Summenformel:
C33H35FN2O5
Molgewicht:
558.64
MOL-Datei:
651770-09-1.mol

(βR,δS)-2-(4-Fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Eigenschaften

Siedepunkt:
722.2±60.0 °C(Predicted)
Dichte
1.23±0.1 g/cm3(Predicted)
pka
4.29±0.10(Predicted)

Sicherheit

(βR,δS)-2-(4-Fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

(βR,δS)-2-(4-Fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid is an intermediate in the synthesis of (3R,5S)-Atorvastatin Sodium Salt (A791725), which is an Atorvastatin impurity in bulk drug and tablets.

(βR,δS)-2-(4-Fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


(βR,δS)-2-(4-Fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 5)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Shijiazhuang yaoBo Pharmaceutical Co., Ltd. 15633056635
2880679888@qq.com China 2881 58
Wuxi Helen Biotechnology Co., Ltd., 0510-85629785 18013409632
sales@reading-chemicals.com China 14081 58
Cato Research Chemicals Inc. 020-81960175-877 18933936954
tianwen.zhan@cato-chem.com China 7733 58
Hubei De'ao Chemical Research Pharmaceutical Technology Co., Ltd 18502726233; 18502726233
3641133981@qq.com China 9809 58

  • (βR,δS)-2-(4-Fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid
  • 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, (βR,δS)-
  • Atorvastatin calcium impurity B02
  • (3R,5S)-Atorvastatin EP Impurity B (single configuration) Calcium salt
  • 651770-09-1
Copyright 2019 © ChemicalBook. All rights reserved